Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1988 of 6351
-
New study aims to improve cervical cancer screening for women in botswana
Diagnosis OngoingPrimary high-risk human papillomavirus (HPV) testing has become first line screening for cervical cancer in high-income countries. The feasibility of this approach in low- and middle-income countries (LMICs) is less clear, as is the role of HPV testing among women living with hum…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
Can a biologic drug heal the skin barrier in kids with eczema?
Disease control CompletedPrimary Objective: \- Evaluate changes in skin barrier function with transepidermal water loss (TEWL) assessed after skin tape stripping (STS) in predefined lesional skin in pediatric participants with moderate to severe atopic dermatitis (AD) treated with dupilumab. Secondary …
Phase 4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 17:25 UTC
-
Stomach cancer trial combines Belly-Infused chemo with standard drugs
Disease control OngoingThis is a phase II clinical trial assessing the safety and efficacy of sequential systemic and intraperitoneal (IP) chemotherapy in patients with primary gastric/gastroesophageal junction cancer with cytology positive peritoneal lavage and/or peritoneal carcinomatosis.
Phase 2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Eating within a 10-Hour window may help prevent a common cancer
Prevention CompletedThe long-term goal of this study is to determine the efficacy of time restricted eating (TRE) for improving metabolic health and preventing endometrial cancer. The primary objective of the protocol is to conduct a 14-week two-arm randomized crossover trial of a dietary interventi…
Sponsor: University of Utah • Aim: Prevention
Last updated Jul 31, 2026 00:00 UTC
-
Virtual asthma care keeps teens out of the ER
Disease control OngoingLow-income, minority teenagers have disproportionately high rates of asthma morbidity, including excess risk of emergency department visits, hospitalizations, and death from asthma. Despite well established guidelines, under-treatment for asthma is common, particularly for poor u…
Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Breathing breakthrough: safer ventilation during emergency surgery could save lives
Disease control CompletedThe aim of this study is to compare the effects of a strategy aimed at increasing alveolar recruitment (high PEEP levels adjusted according to driving pressure and recruitment maneuvers) with that of a strategy aimed at minimizing alveolar distension (low PEEP level without recru…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Poop pills vs. superbugs: can a fecal transplant beat resistant gut bacteria?
Disease control Recruiting nowRates of antimicrobial resistance are increasing worldwide. There is increasing evidence that physiological gut microbiota is a large reservoir of antibiotic-resistance genes. Healthy gut microbiota is known to prevent the colonization of the gastrointestinal tract by pathogens, …
Phase 1/2 • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Smart scans and DNA tests could revolutionize liver cancer care
Knowledge-focused CompletedThis will be a prospective, observational, cohort study to determine the impact of integrated diagnostics using quantitative magnetic resonance imaging, whole genome sequencing and digital pathology on intended patient management for liver cancer patients referred for liver resec…
Sponsor: Perspectum • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can a pneumonia shot boost CAR T-Cell success in lymphoma?
Disease control OngoingThe purpose of the study is to evaluate whether receiving the pneumococcal 13-valent conjugate vaccine (PCV13) before and after CD19-targeted CAR T cell therapy will optimize cellular and humoral immunity to pneumococcus.
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New split-dose chemo aims to help elderly lymphoma patients
Disease control OngoingThis study is investigating a new administration schedule of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (R-CHOP) chemotherapy for participants with Diffuse Large B-Cell Lymphoma (DLBCL), focusing on an underserved elderly population (aged 75 and up; certain…
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Glowing nanoparticles could help surgeons see hidden prostate cancer
Diagnosis Recruiting nowThe purpose of this study is to see whether using the copper-64 (64Cu) or zirconium-89 (89Zr) radiolabeled PSMA-targeting C' dot tracer, termed 64Cu-NOTA-PSMAi-PEG-Cy5.5-C' dots or 89Zr-DFO-PSMAi-PEG-Cy5.5-C' dots, is a safe way to identify tumor cells before and during surgery f…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 13:08 UTC
-
Cord blood cells join forces with drug to fight transplant complication
Disease control Recruiting nowThis early phase I trial is to find out the effect of adding cord blood tissue-derived mesenchymal stromal cells (cb-MSCs) to ruxolitinib in treating patients with acute graft versus host disease that does not respond to steroid therapy (steroid-refractory). Ruxolitinib may stop …
Early phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New hope for kidney transplant patients: cholesterol drug evolocumab shows promise
Disease control CompletedCardiovascular disease is the leading cause of mortality after renal transplantation, accounting for more than 30% of deaths. Elevated lipid levels (hyperlipidemia) are a frequent finding following transplantation and the immunosuppressive medications play a central role in the d…
Phase 4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New blood test could end painful liver biopsies for millions
Diagnosis CompletedThe NAFLD is the first cause of liver disease worldwide. The severe form of NAFLD, the NASH progresses to cirrhosis and is responsible of liver mortality. The diagnosis of NASH requires liver biopsy that cannot be used for the screening of the disease. The broad prevalence of th…
Sponsor: University Hospital, Lille • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Can an enzyme shield the gut during transplant recovery?
Disease control OngoingStudy Objectives: 1. To evaluate the safety and tolerability of oral SYN-004 in adult allogeneic HCT (allo-HCT) recipients who develop fever after conditioning therapy and are treated with IV β-lactam antibiotics meropenem (MER), piperacillin tazobactam (PIP/TAZO), or cefepime (…
Phase 1/2 • Sponsor: Theriva Biologics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can a dental floss loop make polyp removal faster?
Disease control CompletedPatients scheduled for an endoscopic submucosal dissection(ESD) in the colorectum will be randomized to the use of a traction device(consisting of an endoscopic clip with a loop of dental floss secured in the lesion to be removed, another clip will anchor the loop to adjacent bow…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Daily aspirin may shield hearts after preeclampsia
Disease control Recruiting nowThis is a single-center, double-blind, randomized, placebo-controlled clinical trial. Peripartum and postpartum Activin A are significantly elevated in women with preeclampsia. Our hypothesis is that elevated Activin A levels reflect a remediable signal and that reducing postpart…
Phase 4 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Brain zaps for PTSD? small study tests TMS on trauma
Symptom relief CompletedThe study will (1) assess feasibility of a TMS treatment in an underserved population; (2) determine if this TMS treatment protocol improves PTSD symptoms and biological markers of PTSD such as brain functioning and startle responses; (3) define new brain targets for future TMS s…
Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Trusted adults may keep At-Risk teens off opioids
Prevention CompletedAcross the US, substance use is a significant public health concern, with juvenile justice (JJ)-involved youth representing a particularly vulnerable population. The current study proposes to adapt and test an intervention Trust-based Relational Intervention® (TBRI®) for preventi…
Sponsor: Texas Christian University • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Can a Parkinson's drug boost brain function in depressed seniors?
Disease control CompletedLate-Life Depression (LLD), or depression in older adults, often presents with motivational deficits, deficits in performance in cognitive domains including processing speed and executive dysfunction, and mobility impairments. This triad of findings implicate dopaminergic dysfunc…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC